syndrome. It has been well know the epithelium ion channels play important role in alveolar fluid homeostasis, under the regulation of inflammation cascades. Activation of sodium-potassium-chloride cotransporter NKCC1 may suppress AFC and may reciprocally modulate inflammatory response. Activation of alveolar macrophages has been recognized as an initiation in the pathogenesis of acute lung injury. In this study we investigated the changes of NKCC1 in macrophage of pneumonia patients and in a mouse macrophage cell line.
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Methods: Six patients who were intubated due to acute respiratory failure were enrolled. After completing the informed consent, patients received a bronchoscopy to collect bronchoalveolar lavage fluid (BALF) within 48 h. The BALF was analyzed for alveolar Macrophage P-NKCC1 expression and cytokine production. In cell culture experiment, RAW 264.7 cells were stimulated with LPS (2ug/mL) and p-NKCC1 expression and cytokine production were evaluated.
Results: The expression of p-NKCC1 on alveolar macrophages was increased in patients with pneumonia/ARDS. The BALF protein, LDH, TNF-α, and IL-1β were also increased. LPS stimulation significantly increased NFκB expression in RAW 264.7 cells, while pretreated with bumetanide (NKCC1 inhibitor) inhibited the expression of NKCC1, NFκB, and TLR4 and increased IκB-α expression. and transforming growth factor β (TGFβ) cause acquisition of epithelialmesenchymal transition (EMT). Although hypoxia-inducible factor 1α (HIF1α) activate the transcription of genes that might be associated with fibrosis development, several studies demonstrate that stabilized hypoxiainducible factor 1α (HIF1α) protein expression might protect from acute lung injury. Thus, whether the stabilized expression of HIF1α protein negatively regulate TGFβ-induced extracellular matrix protein (ECM) production remains elusive. We reassessed the biological role of persistent hypoxia and stabilized HIF1α expression on TGFβ-induced EMT.
Methods: Firstly, we evaluated the effect of HIF1α-stabilization on TGFβ-induced ECM production in human alveolar/epithelial cells treated with prolyl hydroxylase 2 (PHD2) inhibitor. Next, we examined the effect of PHD2 inhibitor on TGFβ-induced ECM production in human fibroblasts. Finally, we assessed the effect of PHD2 inhibitor on Rat lung epithelial cells.
Results: Our data showed that stabilized HIF1α protein expression could repress TGFβ-induced ECM production in not only epithelial cells but also fibroblasts. In addition, similar effects were observed in rat alveolar epithelial cells too.
Conclusion:
Together, the data indicate that HIF1α protein stabilization might be a hopeful target for providing a new therapeutic strategy for lung fibrosis. arately. The apoptotic cell death was monitored by TUNEL assay and Annexin V/PI stain. Heteronemin treatment-related changes of protein expression of Bcl-2, Bax, caspase-3 and 9 were examined by western blot. Mitochondrial function was determined through monitoring changes of mitochondrial membrane potential via Rhodamine 123 reagent. Western blot analysis of the release of cytochrome C from mitochondria to cytosol was also conducted. The mitochondrial ROS inhibitor, mitoTEMPO, was used to test roles of mitochondrial ROS in apoptotic induction.
Results: Our data revealed heteronemin significantly suppressed the growth of human lung A549 cells, glioblastoma U87 cell; however, normal gingival fibroblast (HGF) cells were not affected. Heteronemin treatment upregulated Bad, cleaved caspase-3 and -9. The expression of cytosolic cytochrome c was also increased, along with increasing dose of heteronemin. In addition, oxidative stress of mitochondria and percentage of dissipation of mitochondrial membrane were increased after heteronemin treatment. Furthermore, supplementation with mitoTEMP, mitochondrial ROS scavenger, obviously inhibited apoptotic cell death of A549 cells. 
Conclusion

